Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00064025Phase 2Completed
A Phase 2 trial of medroxyprogesterone acetate in endometrial adenocarcinoma, sponsored by GOG Foundation. Started Apr 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00064025.